Concern over the long-term viability of financial institutions led UK government-owned emerging market investment vehicle the CDC Group to opt for a fully collateralised buy-in when offloading its pension liabilities in a £370 million deal with Goldman Sachs’ offshoot Rothesay Life.
According to John Deed, a trustee of the CDC Group’s pension scheme, uncertainty over the global economy made the issue of securing a collateral-based deal all the more pressing: “We moved from a situation where fina
The week on Risk.net, October 6-12, 2017Receive this by email
- Quantile, TriOptima face off in cleared swaps compression battle
- Leaked EU doc could shield legacy swaps from clearing grab
- ABS set for revival under US Treasury’s liquidity buffer plans
- SGX, HKEX expect to be among first wave of Mifid II equivalence
- Industry hails potential US relaxation of margin timing rules